医学
针灸科
干刺
弹性蛋白
面部肌肉
细胞外基质
神经血管束
病理
伤口愈合
皮肤病科
成纤维细胞
脚踝
疤痕
人体皮肤
叙述性评论
皱纹
外科
皮肤老化
再生(生物学)
经皮
皮肤修复
作者
Magdalena Grzonkowska,Jagoda Baumgart,Michał Kułakowski,Mariusz Baumgart
摘要
ABSTRACT Background Cosmetic acupuncture is increasingly used for facial rejuvenation, but many proposed mechanisms are extrapolated from general acupuncture research, skin mechanobiology, wound‐healing models, or related percutaneous procedures. Direct evidence linking facial needling to structural remodeling of human skin remains limited. The aim of this review was to examine the anatomical and mechanobiological basis of cosmetic acupuncture and distinguish demonstrated effects from plausible but unverified mechanisms. Methods MEDLINE/PubMed and ClinicalTrials.gov were searched through 14 September 2026, supplemented by citation tracking and targeted journal and publisher searches. Clinical studies were integrated with evidence from needle biomechanics, fibroblast mechanotransduction, extracellular matrix biology, neurovascular and immune signaling, neuromuscular physiology, and facial anatomy. Evidence was interpreted according to its directness to cosmetic facial needling. Results Acupuncture‐related studies demonstrate connective‐tissue deformation, fibroblast cytoskeletal responses, local purinergic and vascular effects, and context‐dependent neuromuscular changes, although much of this evidence is nonfacial or experimental. Clinical studies suggest improvement in selected wrinkles, folds, and facial‐contour outcomes. Direct evidence of neocollagenesis, elastin remodeling, or persistent extracellular matrix regeneration in human facial skin after conventional filiform cosmetic acupuncture is lacking. Conclusions Cosmetic acupuncture can be viewed as a tissue‐specific mechanical intervention rather than a uniform “rejuvenation” procedure. Depth, anatomical target, manipulation, puncture density, and treatment frequency may influence the biological response. Future studies should directly link defined mechanical exposure and tissue targeting to objective biological and clinical endpoints.
科研通智能强力驱动
Strongly Powered by AbleSci AI